NCT00180232
Withdrawn
Not Applicable
An Open Clinical Trial to Assess the Influence of Newly Prescribed Aminobiphosphonates on Arterial Stiffness (Changes of the Aortal Elasticity Due to a Newly Established Aminobiphosphinate Therapy for the Treatment of Osteoporosis)
Overview
- Phase
- Not Applicable
- Status
- Withdrawn
- Locations
- 1
Overview
Brief Summary
The study tries to reveal if aminobisphosphonates influence aside the bone density also the vascular status in the typical elderly patient population
Detailed Description
The subjects - starting bisphosphonate treatment due to medical reasons - will be additionally investigated as outpatients (arterial stiffness, applanation tonometry), for each subject 3 individual dates with a duration of approx. 30 min each are scheduled, prior to therapy with bisphosphonate, after 3 and 6 month of treatment
Study Design
- Study Type
- Observational
- Time Perspective
- Prospective
Eligibility Criteria
- Ages
- 18 Years to — (Adult, Older Adult)
- Sex
- All
- Accepts Healthy Volunteers
- No
Inclusion Criteria
- •Patients starting an aminobisphosphonate therapy due to medical reasons Broca-index: between -20 and +25% who are willing and capable to confirm written consent to enrolment after ample information has been provided
Exclusion Criteria
- •patients with major cardiovascular disease patients participating in another clinical trial 1month prior to inclusion in this study patients unable or unwilling to give informed consent
Investigators
Study Sites (1)
Loading locations...
Similar Trials
Unknown
Not Applicable
Clinical Results of Bisphosphonate and Denosumab Therapy Following Teriparatide Therapy for JapaneseOsteoporosisNCT02166437Tomidahama Hospital500
Recruiting
Phase 3
Bisphosphonate Use to Mitigate Bone Loss Secondary to Bariatric SurgeryBone LossNCT04922333Wake Forest University Health Sciences200
Completed
Not Applicable
Efficacy and Safety on the Use of Bisphosphonates in PaediatricsBone FragileBisphosphonate-Associated OsteonecrosisChildrenAdverse EventsNCT04012320Centre Hospitalier Universitaire de Nīmes99
Completed
Phase 4
Bisphosphonate Therapy for Osteogenesis ImperfectaOsteogenesis ImperfectaOsteoporosisPaget Disease of BoneNCT00159419Indiana University School of Medicine18
Completed
Phase 2
Bisphosphonate Treatment of Osteogenesis ImperfectaOsteogenesis ImperfectaNCT00063479Novartis Pharmaceuticals158